IO Biotech, Inc. financial data

Symbol
IOBT on Nasdaq
Location
Ole Maaloes Veh 3, Copenhagen, Denmark
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 241 % -70.7%
Debt-to-equity 158 % +948%
Return On Equity -465 % -438%
Return On Assets -181 % -140%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.9M shares +9.21%
Common Stock, Shares, Outstanding 69.7M shares +5.79%
Entity Public Float 60.6M USD +94.9%
Common Stock, Value, Issued 70K USD +6.06%
Weighted Average Number of Shares Outstanding, Basic 66.9M shares +1.61%
Weighted Average Number of Shares Outstanding, Diluted 66.9M shares +1.61%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 67.9M USD -5.81%
General and Administrative Expense 24.1M USD -0.72%
Operating Income (Loss) -92.1M USD +4.53%
Nonoperating Income (Expense) 2.75M USD -63%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -89.3M USD -0.35%
Income Tax Expense (Benefit) -955K USD -171%
Net Income (Loss) Attributable to Parent -88.4M USD +2.19%
Earnings Per Share, Basic -1 USD/shares -13.4%
Earnings Per Share, Diluted -1 USD/shares -13.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.7M USD -61.8%
Assets, Current 36.8M USD -57.3%
Property, Plant and Equipment, Net 544K USD -21.7%
Operating Lease, Right-of-Use Asset 1.3M USD -28.2%
Other Assets, Noncurrent 1.01M USD +9.42%
Assets 40M USD -55.6%
Accounts Payable, Current 5.59M USD +6.3%
Employee-related Liabilities, Current 2.99M USD -16.1%
Liabilities, Current 18.3M USD +14.1%
Operating Lease, Liability, Noncurrent 667K USD -49.7%
Liabilities 39M USD +125%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.17M USD +34.9%
Retained Earnings (Accumulated Deficit) -416M USD -26.9%
Stockholders' Equity Attributable to Parent 911K USD -98.7%
Liabilities and Equity 40M USD -55.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.1M USD +7.46%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -28K USD -155%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 69.7M shares +5.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 77.2M USD +33.2%
Deferred Tax Assets, Gross 77.6M USD +32.9%
Depreciation 61K USD -1.61%
Payments to Acquire Property, Plant, and Equipment 28K USD +155%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.5M USD +7.6%
Lessee, Operating Lease, Liability, to be Paid 1.44M USD -34.6%
Operating Lease, Liability, Current 788K USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 423K USD -47.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 818K USD +2.76%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 66.7M USD +32.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 208K USD +7.77%
Additional Paid in Capital 424M USD +3.12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 300K USD +20%
Deferred Tax Assets, Net of Valuation Allowance 415K USD -13.4%
Share-based Payment Arrangement, Expense 6.29M USD -2.54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%